JPMorgan initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $23 price target The firm says its bullish thesis is based on Camp4’s ASO RNA Actuator Platform ...

Fitness buff Hutch Daily is a foulmouthed 27 yearold with the maturity of a preteen After refusing to find employment or his own apartment his mom gives him two choices move to the homeless ...

Fintel reports that on November 5, 2024, JP Morgan initiated coverage of Camp4 Therapeutics (NasdaqGM:CAMP) with a Overweight recommendation. As of June 12, 2024, the average one-year price target ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

Taking her place next to some gym equipment, Yang Chi’ao waits to be called by an instructor at a weight-loss camp in China, where over half of adults are overweight. These facilities ...